Form EFFECT NERVGEN PHARMA CORP.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 26, 2026 4:00 P.M. |
| Form: | F-10 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raj Subramaniam, President and Chief Executive Officer of FedEx Corporation, Receives Appeal of Conscience Award at 61st Annual Gala in New York
- Xinhua Silk Road: From temple visit to island getaway: Fujian's Meizhou Island expands tourism appeal
- Ethereum Price Prediction Eyes $2,800 After a $144 Million ETF Day as the Remittix PayFi Launch Approaches
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
